KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Vir Biotechnology (VIR) over the last 5 years, with Q1 2025 value amounting to $0.02.

  • Vir Biotechnology's Debt to Equity changed N/A to $0.02 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.02, marking a year-over-year change of. This contributed to the annual value of $0.01 for FY2024, which is N/A changed from last year.
  • Vir Biotechnology's Debt to Equity amounted to $0.02 in Q1 2025.
  • Vir Biotechnology's Debt to Equity's 5-year high stood at $0.08 during Q3 2021, with a 5-year trough of $0.01 in Q4 2024.
  • For the 3-year period, Vir Biotechnology's Debt to Equity averaged around $0.04, with its median value being $0.04 (2021).
  • Data for Vir Biotechnology's Debt to Equity shows a peak YoY increase of 32623.92% (in 2021) and a maximum YoY decrease of 3323.61% (in 2021) over the last 5 years.
  • Quarter analysis of 3 years shows Vir Biotechnology's Debt to Equity stood at $0.08 in 2021, then tumbled by 82.14% to $0.01 in 2024, then increased by 20.09% to $0.02 in 2025.
  • Its last three reported values are $0.02 in Q1 2025, $0.01 for Q4 2024, and $0.08 during Q3 2021.